Chezy Barenholz

Cannabinoids-focused pharmaceutical company Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTC:INNPF) said on Tuesday it expects its preliminary revenues in the fourth quarter of fiscal 2023 to equal to $4.89 million, representing a sequential and year-over-year increase of 20% and 331%,...